Skip to main content

Dermatophyte Infections

  • Chapter
  • First Online:
European Handbook of Dermatological Treatments

Abstract

Dermatophyte infections, also known as tinea, are the most common type of fungal infections in the skin, nail, and hair. Dermatophytes are a group of fungi that require keratin in order for growth. Their spread can be through direct or indirect forms of contact from other people, animals, and habitats. In this chapter, we will address the aetiology and treatment of Tinea corporis, Tinea cruris, Tinea capitis, and Onychomycosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 349.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 449.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Further Reading

  • Banerjee M, Ghosh AK, Basak S, Das KD, Gangopadhyay DN. Comparative evaluation of effectivity and safety of topical amorolfine and clotrimazole in the treatment of tinea corporis. Indian J Dermatol. 2011;56(6):657.

    ArticleĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  • Baran R, Feuilhade M, Datry A, et al. A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophyte toenail onychomycosis affecting the matrix region. Br J Dermatol. 2001;142:1177ā€“83.

    ArticleĀ  Google ScholarĀ 

  • Baran R, Tosti A. Chemical avulsion with urea nail lacquer. J Dermatol Treat. 2002;13(4):161ā€“4.

    ArticleĀ  CASĀ  Google ScholarĀ 

  • Baran R, Sigurgeirsson B, de Berker D, Kaufmann R, Lecha M, Faergemann J, Sidou F. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement. Br J Dermatol. 2007;157(1):149ā€“57.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Baran R, Tosti A, Hartmane I, Altmeyer P, Hercogova J, Koudelkova V, Mikazans I. An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis. J Eur Acad Dermatol Venereol. 2009;23(7):773ā€“81.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Bell-Syer S, Khan S, Torgerson D. Oral treatments for fungal infections of the skin of the foot. Cochrane Database Syst Rev. 2012;10:CD003584.

    PubMedĀ  Google ScholarĀ 

  • Bennet ML, Fleischer AB, Loveless JW, et al. Oral griseofulvin remains the treatment of choice for tinea capitis in children. Pediatr Dermatol. 2000;17:304ā€“9.

    ArticleĀ  Google ScholarĀ 

  • Brautigam M, Nolting S, Schpf RE, et al. Randomized double blind comparison terbinafine itraconazole for treatment toenail tinea infection. Br Med J. 1995;311:919ā€“22.

    ArticleĀ  CASĀ  Google ScholarĀ 

  • Ceschin-Roques CG, Hanel H, Pruja-Bougaret SM, et al. Ciclopirox nail lacquer 8%: in vivo penetration into and through nails and in vitro effect on pig skin. Skin Pharmacol. 1991;4:89ā€“94.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Chang C-H, Young-Xu Y, Kurth T, Orav JE, Chan AK. The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis. Am J Med. 2007;120(9):791ā€“8. e793

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Chauvin D, Feuilhade M, ViguiĆ©-Vallanet C, Kienzler JL, Larnier C. Novel, single-dose, topical treatment of tinea pedis using terbinafine: results of a dose-finding clinical trial. Mycoses. 2008;51(1):1ā€“6.

    PubMedĀ  Google ScholarĀ 

  • Chen C, Koch LH, Dice JE, Dempsey KK, Moskowitz AB, Barnes-Eley ML, Williams JV. A randomized, double-blind study comparing the efficacy of selenium sulfide shampoo 1% and Ciclopirox shampoo 1% as adjunctive treatments for tinea Capitis in children. Pediatr Dermatol. 2010;27(5):459ā€“62.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  • De Doncker P, Decroix J, Pierard GE, et al. Antifungals pulse therapy for onychomycosis. Arch Dermatol. 1996;132:34ā€“41.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Dominicus R, Weidner C, Tate H, Kroon HA. Open-label study of the efficacy and safety of topical treatment with TDT 067 (terbinafine in TransfersomeĀ®) in patients with onychomycosis. Br J Dermatol. 2012;166(6):1360ā€“2.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Elewski BE. Tina capitis: a current perspective. J Am Acad Dermatol. 2000;42:1ā€“20.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Elewski BE, Rich P, Pollak R, Pariser DM, Watanabe S, Senda H, Ramakrishna T. Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies. J Am Acad Dermatol. 2012;68:600.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  • Elewski B, Ghannoum M, Mayser P, Gupta A, Korting HC, Shouey R, Hugot S. Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs. J Eur Acad Dermatol Venereol. 2011;27:287.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  • Faergemann J, Mƶrk N, Haglund A, ƖdegĆ rd T. A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris. Br J Dermatol. 1997;136(4):575ā€“7.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Figueiredo Souza L, Souza S, Botelho A. Randomized controlled trial comparing photodynamic therapy based on methylene blue dye and fluconazole for toenail onychomycosis. Dermatol Ther. 2013;27:43.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  • Ginter-Hanselmayer G, Weger W, Ilkit M, Smolle J. Epidemiology of tinea capitis in Europe: current state and changing patterns. Mycoses. 2007;50(s2):6ā€“13.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  • GonzĆ”lez U, Seaton T, Bergus G, Jacobson J, MartĆ­nez-MonzĆ³n C. Systemic antifungal therapy for tinea capitis in children. Cochrane Database Syst Rev. 2007;(4):CD004685.

    Google ScholarĀ 

  • Grover C, Bansal S, Nanda S, Reddy B, Kumar V. Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial. Br J Dermatol. 2007;157(2):364ā€“8.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Gupta AK, Lynde CW, Konnikow N. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toe- nail onychomycosis. J Am Acad Dermatol. 2001;44:485ā€“891.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Gupta AK, Shear NH. A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis. Drug Saf. 2000;22:33ā€“52.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Gupta AK, Drummond-Main C. Meta-analysis of randomized, controlled trials comparing particular doses of Griseofulvin and Terbinafine for the treatment of Tinea capitis. Pediatr Dermatol. 2013;30(1):1ā€“6.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  • Gupta AK, Drummond-Main C, Paquet M. Evidence-based optimal fluconazole dosing regimen for onychomycosis treatment. J Dermatolog Treat. 2013;24:75ā€“80.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Gupta A, Paquet M, Simpson F, Tavakkol A. Terbinafine in the treatment of dermatophyte toenail onychomycosis: a meta-analysis of efficacy for continuous and intermittent regimens. J Eur Acad Dermatol Venereol. 2012;27:267.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  • Hafeez F, Hui X, Selner M, Rosenthal B, Maibach H. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers. Drug Dev Ind Pharm. 2013;40:838ā€“44.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  • Hay RJ, Baran R. Onychomycosis: a proposed revision of the clinical classification. J Am Acad Dermatol. 2011;65(6):1219ā€“27.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  • Hochman LG. Laser treatment of onychomycosis using a novel 0.65-millisecond pulsed Nd: YAG 1064-nm laser. J Cosmet Laser Ther. 2011;13(1):2ā€“5.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  • Jerajani H, Janaki C, Kumar S, Phiske M. Comparative assessment of the efficacy and safety of sertaconazole (2%) cream versus terbinafine cream (1%) versus luliconazole (1%) cream in patients with dermatophytoses: a pilot study. Indian J Dermatol. 2013;58(1):34.

    ArticleĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  • Katsambas A, Antoniou C, Frangouli E, et al. Itraconazole in the treatment of tinea corporis and tinea Curtis. Clin Exp Dermatol. 1993;18:322ā€“5.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Lecha M, Effendy I, Feuilhade de Chauvin M, Di Chiacchio N, Baran R. Treatment optionsā€“development of consensus guidelines. J Eur Acad Dermatol Venereol. 2005;19(s1):25ā€“33.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  • Montero JF. Fuconazole in the treatment of tinea capitis. Int J Dermatol. 1998;37:870ā€“3.

    Google ScholarĀ 

  • Nozickova M, Koudelkova V, Kulikova Z, Malina L, Urbanowski S, Silny W. A comparison of the efficacy of oral fluconazole, 150 mg/week versus 50 mg/day, in the treatment of tinea corporis, tinea cruris, tinea pedis, and cutaneous candidosis. Int J Dermatol. 1998;37(9):703ā€“5.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Piraccini BM, Sisti A, Tosti A. Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents. J Am Acad Dermatol. 2010;62(3):411ā€“4.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  • Rotta I, Ziegelmann PK, Otuki MF, Riveros BS, Bernardo NL, Correr CJ. Efficacy of topical antifungals in the treatment of dermatophytosis: a mixed-treatment comparison meta-analysis involving 14 treatments. JAMA Dermatol. 2013;149(3):341ā€“9.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Savin RS. Treatment of chronic tinea pedis (athleteā€™s foot type) with topical terbinafine. J Am Acad Dermatol. 1990;23:786ā€“9.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Shemer A, Plotnik IB, Davidovici B, Grunwald MH, Magun R, Amichai B. Treatment of tinea capitisā€“griseofulvin versus fluconazoleā€“a comparative study. J Dtsch Dermatol Ges. 2013;11:737.

    PubMedĀ  Google ScholarĀ 

  • Sigurgeirsson B, Olafsson J, Steinsson J, Kerrouche N, Sidou F. Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years. J Eur Acad Dermatol Venereol. 2010;24(8):910ā€“5.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Sigurgeirsson B, van Rossem K, Malahias S, Raterink K. A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis. J Am Acad Dermatol. 2013;69:416.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Singal A, Pandhi D, Agrawal S, Das S. Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: a randomized, double-blind trial. J Dermatol Treat. 2005;16(5-6):331ā€“5.

    ArticleĀ  CASĀ  Google ScholarĀ 

  • Svejgaard EL. Recalcitrant dermatophyte infection. Dermatol Ther. 1997;3:79ā€“83.

    Google ScholarĀ 

  • Tey HL, Tan ASL, Chan YC. Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis. J Am Acad Dermatol. 2011;64(4):663ā€“70.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Tietz HJ, Hay R, Querner S, Delcker A, Kurka P, Merk HF. Efficacy of 4 weeks topical bifonazole treatment for onychomycosis after nail ablation with 40% urea: a double-blind, randomized, placebo-controlled multicenter study. Mycoses. 2013;56:414.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Tosti A, Piraccini BM, Stinchi C, et al. Relapses of onychomycosis after successful treatment with systemic antifungals: a three year follow-up. Dermatology. 1998;197:162ā€“6.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Tosti A, Piraccini BM, Stinchi C, et al. Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy. J Am Acad Dermatol. 1996;34:595ā€“600.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Tosti A, Piraccini BM. Treatment of onychomycosis: a European experience. Dermatol Ther. 1997;3:79ā€“83.

    Google ScholarĀ 

  • Trivedi N, Shah P. A meta-analysis comparing efficacy of continuous terbinafine with intermittent itraconazole for toenail onychomycosis. Indian J Dermatol. 2010;55(2):198.

    ArticleĀ  CASĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  • Yin Z, Xu J, Luo D. A meta-analysis comparing long-term recurrences of toenail onychomycosis after successful treatment with terbinafine versus itraconazole. J Dermatol Treat. 2012;23(6):449ā€“52.

    ArticleĀ  CASĀ  Google ScholarĀ 

  • Zaias N. Onychomycosis. Arch Dermatol. 1972;105:263ā€“74.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rebecca QuiƱonez .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

Ā© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

QuiƱonez, R., Piraccini, B.M., Tosti, A. (2023). Dermatophyte Infections. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D'Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Cham. https://doi.org/10.1007/978-3-031-15130-9_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-15130-9_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-15129-3

  • Online ISBN: 978-3-031-15130-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics